Are you Dr. Collisson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 64 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000
Summary
- Dr. Eric Collisson, MD is an oncologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and California. He is affiliated with Fred Hutch Cancer Center and is an Instructor at UCSF School of Medicine.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2005 - 2007
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2003 - 2005
David Geffen School of Medicine at UCLAClass of 2002
Certifications & Licensure
CA State Medical License 2004 - 2026
WA State Medical License 2024 - 2025
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- AI-Driven insights in pancreatic cancer imaging: from pre-diagnostic detection to prognostication.Ajith Antony, Sovanlal Mukherjee, Yan Bi, Eric A Collisson, Madhu Nagaraj
Abdominal Radiology. 2024-12-30 - Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning.Gabriella O Estevam, Edmond M Linossi, Jingyou Rao, Christian B Macdonald, Ashraya Ravikumar
Biorxiv. 2024-12-05 - Assessing Large Language Models for Oncology Data Inference From Radiology Reports.Li-Ching Chen, Travis Zack, Arda Demirci, Madhumita Sushil, Brenda Miao
JCO Clinical Cancer Informatics. 2024-12-01
Press Mentions
‘Exciting Time in Precision Medicine:’ Fred Hutch Symposium Offers National Leaders in Cancer VaccinesSeptember 27th, 2024- Is Iron the Achilles’ Heel for Cancer?April 4th, 2022
- Cancer Cells Feed on Iron: Scientists Have an AdvantageApril 3rd, 2022
- Join now to see all
Grant Support
- A Model For Preclinical Biomarker Discovery In Pancreatic Ductal AdenocarcinomaNational Cancer Institute2010–2011
